|AJCC cancer staging manual|
MB Amin, SB Edge
|A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival|
M Lacroix, D Abi-Said, DR Fourney, ZL Gokaslan, W Shi, F DeMonte, ...
Journal of neurosurgery 95 (2), 190-198, 2001
|Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer|
C Liedtke, C Mazouni, KR Hess, F André, A Tordai, JA Mejia, ...
Journal of clinical oncology 26 (8), 1275-1281, 2008
|Breast cancer molecular subtypes respond differently to preoperative chemotherapy|
R Rouzier, CM Perou, WF Symmans, N Ibrahim, M Cristofanilli, ...
Clinical cancer research 11 (16), 5678-5685, 2005
|Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases|
EK Abdalla, JN Vauthey, LM Ellis, V Ellis, R Pollock, KR Broglio, K Hess, ...
Annals of surgery 239 (6), 818, 2004
|Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial|
EL Chang, JS Wefel, KR Hess, PK Allen, FF Lang, DG Kornguth, ...
The lancet oncology 10 (11), 1037-1044, 2009
|Experience with 1509 patients undergoing thoracoabdominal aortic operations|
LG Svensson, ES Crawford, KR Hess, JS Coselli, HJ Safi
Journal of vascular surgery 17 (2), 357-370, 1993
|Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma|
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
|Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients|
ES Crawford, JL Crawford, HJ Safi, JS Coselli, KR Hess, B Brooks, ...
Journal of vascular surgery 3 (3), 389-404, 1986
|Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials|
ET Wong, KR Hess, MJ Gleason, KA Jaeckle, AP Kyritsis, MD Prados, ...
Journal of Clinical Oncology 17 (8), 2572-2572, 1999
|Melanoma staging: evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual|
JE Gershenwald, RA Scolyer, KR Hess, VK Sondak, GV Long, MI Ross, ...
CA: a cancer journal for clinicians 67 (6), 472-492, 2017
|Deep hypothermia with circulatory arrest: determinants of stroke and early mortality in 656 patients|
LG Svensson, ES Crawford, KR Hess, JS Coselli, S Raskin, SA Shenaq, ...
The Journal of thoracic and cardiovascular surgery 106 (1), 19-31, 1993
|Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer|
KR Hess, K Anderson, WF Symmans, V Valero, N Ibrahim, JA Mejia, ...
Journal of clinical oncology 24 (26), 4236-4244, 2006
|Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low-to intermediate-grade neuroendocrine tumors: results of a phase II study|
JC Yao, AT Phan, DZ Chang, RA Wolff, K Hess, S Gupta, C Jacobs, ...
Journal of Clinical Oncology 26 (26), 4311, 2008
|Metastatic patterns in adenocarcinoma|
KR Hess, GR Varadhachary, SH Taylor, W Wei, MN Raber, R Lenzi, ...
Cancer 106 (7), 1624-1633, 2006
|The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models|
Nature biotechnology 28 (8), 827, 2010
|Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors|
R Sawaya, M Hammoud, D Schoppa, KR Hess, SZ Wu, WM Shi, ...
Neurosurgery 42 (5), 1044-1055, 1998
|Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer|
M Ayers, WF Symmans, J Stec, AI Damokosh, E Clark, K Hess, M Lecocke, ...
Journal of clinical oncology 22 (12), 2284-2293, 2004
|Surgical treatment of aneurysm and/or dissection of the ascending aorta, transverse aortic arch, and ascending aorta and transverse aortic arch: factors influencing survival in …|
ES Crawford, LG Svensson, JS Coselli, HJ Safi, KR Hess
The Journal of thoracic and cardiovascular surgery 98 (5), 659-674, 1989
|Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alfa-2b|
JC Yao, A Phan, PM Hoff, HX Chen, C Charnsangavej, SCJ Yeung, ...
Journal of Clinical Oncology 26 (8), 1316-1323, 2008